retatrutide with mots c + MOTS-c Peptide Stack Guide: Dosing, Reconstitution & Safety (2026) MOTS-C 20mg - Source307

Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial

Aging Cell

The study, published in JAMA , found these adverse gastrointestinal effects happen in non-diabetic patients using the drugs specifically for weight loss

The use of Ozempic for weight loss in non-diabetic individuals is still relatively new, and its essential to follow a healthcare professionals guidance to ensure safety and effectiveness in achieving weight management goals

It treats ordinary bruising that fades on the usual timeline as unremarkable, and reserves escalation for the cases that behave differently from the pattern it describes elsewhere in the piece